SG Americas Securities’s 2seventy bio TSVT Stock Holding History
Bought
Maintained
Sold
Other funds holding TSVT
SG Americas Securities's TSVT Position: Q2 2025 in Review
SG Americas Securities sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 15,917 shares — an estimated $79K sold.
SG Americas Securities first reported a position in TSVT in Q4 2021 and held it in 11 quarters. The position peaked at $381K in Q2 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.
- SG Americas Securities reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
- SG Americas Securities sold 15,917 2seventy bio shares in Q2 2025, an estimated $79K.
- SG Americas Securities first reported a position in 2seventy bio in Q4 2021 and held it in 11 quarters.
- SG Americas Securities's 2seventy bio position peaked at $381K in Q2 2022.
- 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.
Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.